Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://albiegewn912160.fireblogz.com/70302707/semaglutide-a-potential-solution-for-obesity